Vimarsana
Biggest News Aggregation in the World

Page 28 - Ouse Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ouse Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ouse Model Today - Breaking & Trending Today

Novel experimental system traces the development and longevity of plasma cells - Vimarsana News

Novel experimental system traces the development and longevity of plasma cells

Just as a fire department mobilizes in response to a reported fire, specialized immune cells in the body mobilize in response to the introduction of foreign substances known as antigens.

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model - Vimarsana News

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

In a recent study posted to bioRxiv*, researchers in the United States assessed the impact of metabolic diseases on coronavirus disease 2019 (COVID-19) vaccine immunogenicity in a mouse model.

Study provide new insights into why cholestasis causes cognitive issues - Vimarsana News

Study provide new insights into why cholestasis causes cognitive issues

Patients with cholestatic liver disease such as primary biliary cholangitis (PBC) can experience significant impairment of bile flow and may develop neurological symptoms including fatigue and cognitive decline.

Mpox virus from Clade 2b is the least virulent strain according to new study - Vimarsana News

Mpox virus from Clade 2b is the least virulent strain according to new study

Researchers used the CAST/EiJ mouse model to test whether genetic differences between clades 1, 2a, and 2b of the monkeypox virus contribute to changes in transmission and virulence of the disease.

Researchers modulate the activity of potential therapeutic target for triple-negative breast cancer - Vimarsana News

Researchers modulate the activity of potential therapeutic target for triple-negative breast cancer

Less than 20% of diagnosed breast cancers are designated "triple-negative," lacking three types of receptors often found in other breast cancer types.